Experience

Anatomic Incorporated

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Jun 2018 - Present

  Minneapolis, Minnesota, United States



University of Minnesota

• United States
• Higher Education
• 700 & Above Employee

• Researcher 3

  • Apr 2014 - Apr 2019

  Greater Minneapolis-St. Paul Area I was responsible for the oversight and execution of translational research concerning the derivation of neural subtypes from human pluripotent stem cells. I have developed a novel method for rapid production of anterior neuroepithelium and neuromesoderm, from which I have derived midbrain floorplate dopaminergic neurons, cranial neural crest, ectomesenchyme, peripheral neurons, schwann cells, trunk neural crest and derivatives, spinal interneuron and motor neuron subtypes, spinal floorplate… Show more I was responsible for the oversight and execution of translational research concerning the derivation of neural subtypes from human pluripotent stem cells. I have developed a novel method for rapid production of anterior neuroepithelium and neuromesoderm, from which I have derived midbrain floorplate dopaminergic neurons, cranial neural crest, ectomesenchyme, peripheral neurons, schwann cells, trunk neural crest and derivatives, spinal interneuron and motor neuron subtypes, spinal floorplate, and axial skeletal muscle. Show less



Lonza

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research Associate

  • Mar 2011 - Apr 2014

  Walkersville, MD I worked for Lonza--Walkersville, a cGMP manufacturer for the cell therapy industry, as a research associate out of Lonza's Pluripotent Stem Cell Innovation Center, where I was involved in developing technologies supporting the cGMP production, maintenance, expansion, characterization, and banking of pluripotent stem cell lines.



University of Minnesota

• United States
• Higher Education
• 700 & Above Employee

• Graduate Student

  • Aug 2009 - Jan 2011

  I performed thesis research concerning reprogramming technologies, hematopoietic differentiation, and hematopoietic malignancy models based on induced pluripotent stem cells.